News

Market Access/ News/ News/ News/ News/ Oncology/ Patients

NICE endorses Magtrace diagnostic to detect breast cancer spread

Phil Taylor breast cancer, diagnostic, Endomag, NHS, NICE, Oncology 0 Comment

Women with breast cancer in England and Wales will soon be able to access a new diagnostic based

NICE endorses Magtrace diagnostic to detect breast cancer spread

https://pharmaphorum.com/news/nice-endorses-magtrace-diagnostic-to-detect-breast-cancer-spread/

Market Access/ News/ News/ News/ R&D

AstraZeneca, Avillion ‘first-in-class’ combination inhaler shines in Phase 3 trial

Eloise McLennan albuterol, asthma, Astra Zeneca, Avillion, budesonide 0 Comment

An albuterol/budesonide fixed-dose combination rescue medication has been shown to reduce severe exacerbations in patients with asthma for

AstraZeneca, Avillion ‘first-in-class’ combination inhaler shines in Phase 3 trial

https://pharmaphorum.com/news/astrazeneca-avillion-first-in-class-combination-inhaler/

Market Access/ News/ News

Lilly’s new drug Mounjaro (tirzepatide ) wins US FDA approval

Joy Persaud Diabetes, Lilly, Mounjaro, Type 2 diabetes 0 Comment

Blood sugar control drug Mounjaro has been granted US regulatory approval, giving type 2 diabetics another way to

Lilly’s new drug Mounjaro (tirzepatide ) wins US FDA approval

https://pharmaphorum.com/news/lillys-new-drug-mounjaro-tirzepatide-wins-us-fda-approval/

Market Access/ News/ News

FDA rejects UCB’s psoriasis therapy bimekizumab

Phil Taylor bimekizumab, fda, psoriasis, regulatory, UCB 0 Comment

The FDA has delivered a blow to UCB’s late-stage pipeline, after saying it is unable to approve its

FDA rejects UCB’s psoriasis therapy bimekizumab

https://pharmaphorum.com/news/fda-rejects-ucbs-psoriasis-therapy-bimekizumab/

Market Access/ News/ News/ News/ Patients

Gedeon Richter gets NICE nod for uterine fibroids drug Ryeqo

Phil Taylor Gedeon Richter, HEOR, NHS, NICE, patients, relugolix, uterine fibroids, women's health 0 Comment

Around 4,500 women in the UK will be eligible for treatment with Gedeon Richter’s once-daily oral therapy Ryeqo,

Gedeon Richter gets NICE nod for uterine fibroids drug Ryeqo

https://pharmaphorum.com/news/gedeon-richter-gets-nice-nod-for-uterine-fibroids-drug-ryeqo/

Market Access/ News/ News

Exit Aduhelm, enter lecanemab. Biogen and Eisai have another go

Phil Taylor Aduhelm, Alzheimer's disease, amyloid, Biogen, Eisai, lecanemab, regulatory 0 Comment

Here we go again. With Aduhelm largely sidelined, Biogen and Eisai are hoping for a better fortunes with

Exit Aduhelm, enter lecanemab. Biogen and Eisai have another go

https://pharmaphorum.com/news/exit-aduhelm-enter-lecanemab-biogen-and-eisai-have-another-go/

Market Access/ News/ News

Takeda spinout Phathom claims its first FDA approvals

Phil Taylor gastroenterology, Helicobacter pylori, Phathom Pharmaceuticals, regulatory approval, Takeda, vonoprazan, Voquezna 0 Comment

Three years after it was formed as a spinout of Japanese drugmaker Takeda, Phathom Pharmaceuticals has racked up

Takeda spinout Phathom claims its first FDA approvals

https://pharmaphorum.com/news/takeda-spinout-phathom-claims-its-first-fda-approvals/

Market Access/ News/ News/ News/ Patients

FDA approves first in vitro test for early Alzheimer’s disease

Phil Taylor Alzheimer's disease, diagnosis, in vitro, neurology, regulatory approval 0 Comment

The US FDA has authorised a new test that can detect amyloid plaques in early-stage Alzheimer’s disease without

FDA approves first in vitro test for early Alzheimer’s disease

https://pharmaphorum.com/news/fda-approves-first-in-vitro-test-for-early-alzheimers-disease/

Market Access/ News/ News/ News/ Oncology

AZ eyes Q3 FDA decision for Imfinzi in biliary tract cancer

Phil Taylor AstraZeneca, biliary tract cancer, Imfinzi, immuno-oncology, Oncology 0 Comment

The FDA has kicked off a priority review of AstraZeneca’s checkpoint inhibitor Imfinzi for biliary tract cancer (BTC),

AZ eyes Q3 FDA decision for Imfinzi in biliary tract cancer

https://pharmaphorum.com/news/az-eyes-q3-fda-decision-for-imfinzi-in-biliary-tract-cancer/

1 2 3 4 ›»

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com

Trending

News

Login